FDA Announces Draft Guidance for Clinical Trials of Cellular and Gene Therapy Products in Small Populations

Summary

The FDA has released a draft guidance document outlining recommendations for sponsors planning clinical trials of cell and gene therapy products for rare diseases or conditions, aiming to expedite drug development and generate data necessary for licensure.